問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberBN160913

2014-05-06 - 2018-11-12

Phase I

Terminated1

ICD-10A48.52

Wound botulism

ICD-10S81.021A

Laceration with foreign body, right knee, initial encounter

ICD-10S81.022A

Laceration with foreign body, left knee, initial encounter

ICD-10S81.029A

Laceration with foreign body, unspecified knee, initial encounter

ICD-10S81.041A

Puncture wound with foreign body, right knee, initial encounter

ICD-10S81.042A

Puncture wound with foreign body, left knee, initial encounter

ICD-10S81.049A

Puncture wound with foreign body, unspecified knee, initial encounter

ICD-10S81.821A

Laceration with foreign body, right lower leg, initial encounter

ICD-10S81.822A

Laceration with foreign body, left lower leg, initial encounter

ICD-10S81.829A

Laceration with foreign body, unspecified lower leg, initial encounter

ICD-10S81.841A

Puncture wound with foreign body, right lower leg, initial encounter

ICD-10S81.842A

Puncture wound with foreign body, left lower leg, initial encounter

ICD-10S81.849A

Puncture wound with foreign body, unspecified lower leg, initial encounter

ICD-10S91.021A

Laceration with foreign body, right ankle, initial encounter

ICD-10S91.022A

Laceration with foreign body, left ankle, initial encounter

ICD-10S91.029A

Laceration with foreign body, unspecified ankle, initial encounter

ICD-10S91.041A

Puncture wound with foreign body, right ankle, initial encounter

ICD-10S91.042A

Puncture wound with foreign body, left ankle, initial encounter

ICD-10S91.049A

Puncture wound with foreign body, unspecified ankle, initial encounter

ICD-9891.1

Open wound of knee, leg (except thigh) and ankle, complicated

  • Sponsor

  • Trial scale

    Taiwan Single Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator 戴念梓 Division of Plastic Surgery

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    9 participants

  • Global

    0 participants